SHS Capital invests in healthcare companies with the ambition to become European champions. Leveraging over 30 years of sector expertise, a specialist network, and deep knowledge in market access, reimbursement, commercialization, M&A, and exits, SHS provides capital, strategic guidance, and synergies across its portfolio to drive value creation in fast-developing markets. Focused on DACH, Nordics, Benelux, and select other European regions, SHS targets companies with enterprise values up to €150M and equity tickets typically between €10M–€50M.
Preferred startup development maturity for initial funding deployment.
Established and growing healthcare companies, healthcare innovators in commercialization and scaling phases
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...